⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19853486 | 0.89 | — | — | |
| SCHEMBL16855061 | 0.82 | — | — | |
| SCHEMBL16248348 | 0.75 | — | — | |
| SCHEMBL21936945 | 0.73 | — | — | |
| SCHEMBL10865439 | 0.73 | MGLL (0.44) | — | |
| SCHEMBL28844201 | 0.73 | HIF1A (0.33) | — | |
| SCHEMBL22541172 | 0.72 | CHRM5 (0.36) | — | |
| SCHEMBL6395909 | 0.69 | — | — | |
| SCHEMBL8444244 | 0.69 | — | — | |
| SCHEMBL23126257 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104046246-A | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PROD & CHEM | 2014-09-17 | — | — | CN | claimed |
| US-20230365594-A1 | THIENOPYRROLE COMPOUNDS | GILEAD SCIENCES, INC. | 2023-11-16 | — | — | US | disclosed |
| US-20230365562-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-11-16 | — | — | US | disclosed |
| CN-116472303-A | Polyacrylate and poly (beta-ester) capsules with improved degradability | 恩盖普有限公司 | 2023-07-21 | — | — | CN | disclosed |
| US-20230183226-A1 | AKT3 MODULATORS | Georgiamune Inc. | 2023-06-15 | — | — | US | disclosed |
| US-11661431-B2 | Thienopyrrole compounds | GILEAD SCIENCES, INC. (US) | 2023-05-30 | — | — | US | disclosed |
| US-11578069-B2 | Compounds for inhibition of α4 β7 integrin | GILEAD SCIENCES, INC. (US) | 2023-02-14 | — | — | US | disclosed |
| US-20220389034-A1 | THIENOPYRROLE COMPOUNDS | GILEAD SCIENCES, INC. | 2022-12-08 | — | — | US | disclosed |
| US-20220135561-A1 | IMIDAZOPYRIDINE DERIVATIVES | GILEAD SCIENCES, INC. | 2022-05-05 | — | — | US | disclosed |
| US-11078199-B2 | Quinolone derivatives as fibroblast growth factor receptor inhibitors | PRINCIPIA BIOPHARMA, INC. (US) | 2021-08-03 | — | — | US | disclosed |
| WO-2009080351-A1 | COMPOUNDS WITH ANTI-EMETIC EFFECT | SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) | 2009-07-02 | — | — | WO | disclosed |
| EP-2072050-A1 | Compounds with anti-emetic effect | Santhera Pharmaceuticals (Schweiz) AG (CH) | 2009-06-24 | — | — | EP | disclosed |
| US-5889058-A | ANTITUMOR, ANTICANCER AGENT | CELLTECH LIMITED (GB) | 1999-03-30 | — | — | US | disclosed |
| EP-0489579-B1 | Peptidyl derivatives | CELLTECH LTD (GB) | 1995-03-29 | — | — | EP | disclosed |
| EP-0489577-B1 | Peptidyl derivatives | CELLTECH LTD (GB) | 1995-03-22 | — | — | EP | disclosed |
| US-5300501-A | Metalloproteinase inhibitors | CELLTECH LIMITED (GB) | 1994-04-05 | — | — | US | disclosed |
| WO-1992009565-A1 | PEPTIDYL DERIVATIVES | CELLTECH LIMITED (GB) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009564-A1 | PEPTIDYL DERIVATIVES | CELLTECH LIMITED (GB) | 1992-06-11 | — | — | WO | disclosed |
| EP-0489577-A1 | Peptidyl derivatives | CELLTECH LIMITED (GB) | 1992-06-10 | — | — | EP | disclosed |
| EP-0489579-A1 | Peptidyl derivatives | CELLTECH THERAPEUTICS LIMITED (GB) | 1992-06-10 | — | — | EP | disclosed |